The AGCO Equine Medication Use and Awareness Program is an e-learning course that raises horseracing licensees’ awareness of their obligations related to the use of equine medication. This self-directed online e-learning course is designed to help reduce equine medication misuse by horseracing participants.  The AGCO is committed to promoting equine health and safety through education, while also holding those who fail to follow regulations accountable for their actions.  

The AGCO Equine Medication Use and Awareness Program is composed of three e-learning modules that focus on roles and responsibilities, AGCO regulatory requirements and medication use. The program was developed with input from the horse racing industry and aims to educate users on standards for medication use, reduce improper use of medications and affect equine welfare and public confidence in horse racing in a positive way.   

Effective June 2, 2020 for Thoroughbred and Quarter Horse horse racing and June 5, 2020 for Standardbred racing, program completion will be a requirement for any individual found responsible for an equine drug violation, serving as the educational component identified in section 3 of the AGCO Penalty Guidelines for Equine Drug, TC02 and Non-Therapeutic Drug Violations. Individuals required to register for the course as part of a penalty ruling or agreed settlement, must complete it within the prescribed time period.   

The AGCO Equine Medication Use and Awareness Program is designed to be completed at the learner’s own pace, on any device, and can be done all at once or over several sessions. It is available in French and English and is compliant with the Accessibility for Ontarians with Disabilities Act (AODA). 

Line of Business: 

Was this page useful?

Please help us improve the AGCO website by responding to this survey